Caroline Hoffmann: Guidelines for Optimizing NBTXR3 Nanoparticle Injection in Head and Neck Cancer- A Collaborative Achievement
Caroline Hoffmann, Head of Oncology at Owkin, posted on LinkedIn:
“The consensus guidelines describing the optimal intratumoral and intranodal injection of NBTXR3 hafnium oxide nanoparticles in head and neck squamous cell carcinoma (HNSCC) are now available in open access. Congratulations to this amazing international and multidisciplinary panel for the great work! These guidelines are aimed at harmonizing the injection methodology of this novel therapy that is currently under evaluation in HNSCC in a phase III clinical trial.”
View the article attached to the post.
Source: Caroline Hoffmann/LinkedIn
About OncoDaily
OncoDaily was founded in 2023. It is a US-based oncology media platform, which features the latest news, insights, and patient stories from the world of oncology. Within short period of time it became one of the leading oncology media platforms globally.
OncoDaily gathers content from various sources, including social media posts from renowned oncologists from all over the world, news from oncology societies and cancer centers, patient and survivor stories, and career-related information for professionals.
The mission of OncoDaily is to empower patients, survivors, and professionals with the knowledge and inspiration they need to fight cancer. The motto of OncoDaily is “Cancer doesn’t take a day off – neither do we.”